If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,643.00    -58.00 (-2.15%)
Bid:
2,632.00
Ask:
2,633.00
Spread: 1.00 (0.038%)
Market Cap: £23.44b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Annual Financial Report

6 Jun 2025 11:30

RNS Number : 8322L
Experian plc
06 June 2025
 

Experian plc

 

 

Annual Report and Accounts for the year ended 31 March 2025, Notice of Annual General Meeting 2025 and Proxy Form

 

 

6 June 2025 - Experian plc, the global data and technology company (the "Company"), hereby notifies the market, in accordance with UK Listing Rule 6.4.1(R), that the above documents are being submitted to the National Storage Mechanism and they will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Copies of the Annual Report and Accounts and the Notice of Annual General Meeting are also available on the Company's website at www.experianplc.com.

 

The 2025 Annual General Meeting of the Company will be held at The Merrion Hotel, Upper Merrion Street, Dublin 2, D02 KF79, Ireland on Wednesday 16 July 2025 at 9.30am. A summary of the resolutions and the reasons they are being proposed is set out in the explanatory notes which accompany the Notice of Annual General Meeting.

 

 

Contact:

 

Experian

Claire Murphy Deputy Company Secretary +353 (0) 87 421 3311

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSBGGDLXDGDGUL
Date   Source Headline
13th Dec 20184:53 pmRNSElections for first interim dividend
11th Dec 201812:04 pmRNSExperian signs new Revolving Credit Facility
10th Dec 20181:30 pmRNSExperian agrees to acquire Compuscan
6th Dec 20181:47 pmRNSAdditional Listing
30th Nov 20183:34 pmRNSTotal Voting Rights
28th Nov 20187:03 amRNSUpdate on proposed ClearScore acquisition
13th Nov 20187:00 amRNSHalf-Yearly Financial Report
12th Nov 20185:26 pmRNSTransaction in Own Shares
6th Nov 20185:24 pmRNSTransaction in Own Shares
5th Nov 20186:12 pmRNSTransaction in Own Shares
31st Oct 20183:32 pmRNSTotal Voting Rights
30th Oct 20185:36 pmRNSTransaction in Own Shares
29th Oct 20186:02 pmRNSTransaction in Own Shares
23rd Oct 20185:47 pmRNSTransaction in Own Shares
22nd Oct 20186:01 pmRNSTransaction in Own Shares
16th Oct 20186:11 pmRNSTransaction in Own Shares
15th Oct 20186:16 pmRNSTransaction in Own Shares
10th Oct 20185:44 pmRNSTransaction in Own Shares
10th Oct 20189:10 amRNSAdditional Listing
9th Oct 20186:29 pmRNSTransaction in Own Shares
8th Oct 20184:43 pmRNSIrrevocable and non-discretionary arrangement
5th Oct 20185:59 pmRNSTransaction in Own Shares
4th Oct 20185:40 pmRNSTransaction in Own Shares
28th Sep 20183:21 pmRNSTotal Voting Rights
19th Sep 20185:30 pmRNSTransaction in Own Shares
18th Sep 20185:43 pmRNSTransaction in Own Shares
17th Sep 20184:09 pmRNSBlock listing Interim Review
10th Sep 20185:39 pmRNSTransaction in Own Shares
7th Sep 20186:00 pmRNSTransaction in Own Shares
6th Sep 20186:09 pmRNSTransaction in Own Shares
31st Aug 201811:29 amRNSTotal Voting Rights
29th Aug 201811:01 amRNSAdditional Listing
28th Aug 20189:41 amRNSDirectorate Change
17th Aug 201811:00 amRNSDirector/PDMR Shareholding
10th Aug 20185:50 pmRNSTransaction in Own Shares
9th Aug 20185:39 pmRNSTransaction in Own Shares
8th Aug 20185:29 pmRNSTransaction in Own Shares
7th Aug 20185:23 pmRNSTransaction in Own Shares
6th Aug 20185:25 pmRNSTransaction in Own Shares
3rd Aug 20185:45 pmRNSTransaction in Own Shares
3rd Aug 20189:06 amRNSDirector Declaration
2nd Aug 20186:12 pmRNSTransaction in Own Shares
1st Aug 20185:35 pmRNSTransaction in Own Shares
31st Jul 20185:20 pmRNSTransaction in Own Shares
31st Jul 201810:30 amRNSTotal Voting Rights
30th Jul 20185:35 pmRNSTransaction in Own Shares
25th Jul 20189:52 amRNSAdditional Listing
18th Jul 20181:00 pmRNSResult of AGM
13th Jul 20187:00 amRNSTrading Update, First Quarter
29th Jun 20185:49 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.